The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a ...

While somatic gene editing, which is currently used to treat conditions like sickle-cell anemia, only affects the diseased individual, germline editing alters an entire lineage. It’s illegal in the ...

Following a breakthrough 'cure' for sickle cell disease being approved on the NHS, the Mirror sat down with four British ...

Many high risk, high reward medical therapies that use cutting edge science are proving themselves in clinical trials. But are health services ready to pay for them—and how? Marianne Guenot reports On ...

While de-extinction projects capture headlines with dreams of resurrecting mammoths, the same technologies at play — especially CRISPR — are quietly transforming something even more profound: human ...

The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and ...

Sickle cell disease, characterised by the abnormal sickle shape of red blood cells instead of the typical round form, is the UK's most rapidly expanding genetic disorder. This deformation causes ...

Groundbreaking gene-editing treatment exa-cel is now available for NHS patients with sickle cell disease, offering a ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.